title: Host factors affecting antiepileptic drug delivery-pharmacokinetic variability.
abstract: Antiepileptic drugs (AEDs) are the mainstay in the treatment of epilepsy, one of the most common serious chronic neurological disorders. AEDs display extensive pharmacological variability between and within patients, and a major determinant of differences in response to treatment is pharmacokinetic variability. Host factors affecting AED delivery may be defined as the pharmacokinetic characteristics that determine the AED delivery to the site of action, the epileptic focus. Individual differences may occur in absorption, distribution, metabolism and excretion. These differences can be determined by genetic factors including gender and ethnicity, but the pharmacokinetics of AEDs can also be affected by age, specific physiological states in life, such as pregnancy, or pathological conditions including hepatic and renal insufficiency. Pharmacokinetic interactions with other drugs are another important source of variability in response to AEDs. Pharmacokinetic characteristics of the presently available AEDs are discussed in this review as well as their clinical implications.
authors: Dept. of Pharmacy, Faculty of Health Sciences, Oslo University College, Oslo, Norway. cecilie.landmark@hf.hio.no
authors: Cecilie
authors: C
authors: Johannessen Landmark
authors: Svein I
authors: SI
authors: Johannessen
authors: Torbjörn
authors: T
authors: Tomson
mesh_terms: D000042:Absorption; D000927:Anticonvulsants / Q000493:pharmacokinetics*; D001682:Biological Availability; D004827:Epilepsy / Q000378:metabolism*; D006801:Humans
chemical_list: D000927:Anticonvulsants